Affiliation:
1. University of Washington
Abstract
Abstract
Background: Fluoroquinolone use for urinary tract infections has been steadily declining. Gut microbiota is the main reservoir for uropathogenic Escherichia coli but whether the carriage of fluoroquinolone-resistant E. coli has been changing is unknown.
Methods. We determined the frequency of isolation and other characteristics of E. coli nonsuceptible to fluoroquinolones (at ³0.5 mg/L of ciprofloxacin) in 515 and 1605 E. coli-positive fecal samples collected in 2015 and 2021, respectively, from non-antibiotic- taking women of age 50+ receiving care in the Seattle area Kaiser Permanente Washington healthcare system.
Results. Between 2015 and 2021 the prescription of fluoroquinolones dropped nearly three-fold in the study population. During the same period, the rates of gut carriage of fluoroquinolone-resistant E. coli increased from 14.4 % to 19.9% (P=.005), driven by a significant increase of isolates from the recently emerged, pandemic multi-drug resistant clonal group ST1193 (1.7% to 4.3%; P=.007) and those with an incomplete set of or no fluoroquinolone-resistance determining mutations (2.3% to 7.5%; P<.001). While prevalence of the resistance-associated mobile genes among the isolates dropped from 64.1% to 32.6% (P<.001), co-resistance to third generation cephalosporins has increased 21.5% to 33.1%, P=.044).
Conclusion. Despite reduction in fluoroquinolone prescriptions, gut carriage of fluoroquinolone-resistant uropathogenic E. coli increased with a rise of previously sporadic lineages and co-resistance to third generation cephalosporins. Thus, to reduce the rates of antibiotic resistant urinary tract infections, greater focus should be on controlling the gut carriage of resistant bacteria.
Publisher
Research Square Platform LLC
Reference56 articles.
1. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis;Murray CJ;Lancet,2022
2. CDC. Antibiotic Resistance Threats in the United States, 2019. (Centers for Disease, Control and Prevention, Atlanta, GA: U.S. Department of Health and Human Services, CDC, 2019).
3. Antimicrobial stewardship programs in health care systems;MacDougall C;Clin Microbiol Rev,2005
4. High prevalence of antibiotic resistance in commensal Escherichia coli from healthy human sources in community settings;Nji E;Sci Rep,2021
5. Pandemic uropathogenic fluoroquinolone-resistant Escherichia coli have enhanced ability to persist in the gut and cause bacteriuria in healthy women;Tchesnokova VL;Clin Infect Dis,2019